Retired NFL Linemen Face Hidden Heart Disease Risk, Study Finds

A preliminary study of 200 former NFL players reveals that most have undiagnosed coronary artery disease, with linemen showing significantly more plaque, underscoring the need for early risk assessment even in elite athletes.

Chicago Metrowire Staff
••Healthcare
Retired NFL Linemen Face Hidden Heart Disease Risk, Study Finds

Retired NFL players, particularly linemen, may be at high risk of undiagnosed and untreated coronary artery disease (CAD) that often occurs without symptoms, according to new preliminary research presented at the American Heart Association's Scientific Sessions 2026. The study, believed to be the first assessment of coronary plaque in retired professional football players, found that 85% of participants had plaque in their coronary arteries, yet only 13% had a known CAD diagnosis prior to the scan. More than 40% had blockages narrowing at least one artery by more than 50%, and nearly 30% had plaque substantial enough to significantly restrict blood flow to the heart. Despite these findings, less than 10% reported chest pain or shortness of breath.

The research, which focused on 200 retired NFL players enrolled in the GAMEFILM Registry, used coronary computed tomography angiography (CCTA) and Heartflow AI coronary plaque analysis (AI-CPA) to measure the amount and type of plaque. The AI analysis creates a personalized, color-coded 3D model of heart arteries, measuring plaque volume, type, and impact on blood flow. The imaging revealed that 42% of former players had a blockage narrowing at least one artery by more than 50%, and about 1 in 5 had blockages in multiple arteries. On average, nearly 90% of the detected plaque was soft (noncalcified), which is associated with higher disease risk than calcified plaque and cannot be detected by traditional coronary artery calcium scores.

Retired linemen had more plaque and more severe blockages compared with participants who played other positions. When researchers compared total plaque volume for each participant to an age- and sex-matched group, former linemen sat above the median for total plaque volume, while players of other positions ranked well below the median—a statistically significant difference. "We expected to find plaque, but we did not expect to find such a striking gap between how much significant disease these former football players had and how few of them had any symptoms," said study co-author Campbell Rogers, M.D., chief medical officer at Heartflow, Inc. "It is a reminder of how poorly symptoms can track with what is actually happening inside a coronary artery."

The findings underscore that being a former elite athlete does not protect against coronary artery disease later in life. "Plaque can build up in the artery walls for years without affecting blood flow enough to cause symptoms," said American Heart Association volunteer expert Michael Shapiro, M.D., MPH, FAHA, who was not involved in the study. "So, feeling fine does not necessarily mean the arteries are healthy. A plaque can also rupture and cause a clot and heart attack without much warning." Shapiro noted that the message extends to the public: "Everyone should pay attention to risk before symptoms appear. You need to know your cholesterol, blood pressure and family history, and get treatment when it is needed."

Encouragingly, when participants could see the plaque in their arteries, they wanted to act—nearly 90% of those not already taking cholesterol-lowering medications before the analysis said they were ready to start treatment. "The good news is that when CAD is found early, it is very treatable, often with medication and lifestyle changes rather than a medical procedure," said lead study author David Maron, M.D. The research has limitations, including voluntary enrollment and lack of a prospectively enrolled control group of non-athletes, so findings may not be applicable to other athletes or the general population. The study is considered preliminary until published as a full manuscript in a peer-reviewed journal. The American Heart Association's Scientific Sessions 2026 meeting runs Nov. 6-9 in Chicago. For more information on heart health, visit heart.org or stroke.org.

Blockchain Registration

QR Code for Blockchain Registration